{"name":"Shenzhen NewDEL Biotech, Co., Ltd","slug":"shenzhen-newdel-biotech-co-ltd","ticker":"","exchange":"","domain":"","description":"Shenzhen NewDEL Biotech, Co., Ltd is a biotechnology company focused on the development of innovative therapies. The company has a pipeline of 14 drugs, primarily in Phase 1 clinical trials, targeting various therapeutic areas.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOeU8zbmlTNnptMXFfMFVTV3NEdnRVMlZDcUdabkt2ZGtLMTczbFc2S3NmZmlaWXJHZ0VTbnM1cS1NYjlvdGlONmwtbV9faHBQbnZfLTEtek55d2FhdnFKU3ZRa1FQaFNuVTlLUGN1dWc4OEVqSFBCZVFSbk55RWJ3ZXFnSUlhcjJjTW5JNHh6Xy1MYUYw?oc=5","date":"2022-12-06","type":"pipeline","source":"Frontiers","summary":"3CLpro inhibitors: DEL-based molecular generation - Frontiers","headline":"3CLpro inhibitors: DEL-based molecular generation","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}